ABSTRACT
INTRODUCTION
The rate of death from injury, for which hemorrhagic shock is a major contributing factor, is estimated to reach more than 8 million per year globally by 2020. [1, 2] Fluid therapy is a commonly accepted treatment for resuscitating trauma patients. However, controversy exists over the choice of fluid therapy, (such as colloids or crystalloids) to manage uncontrolled hemorrhagic shock (UHS) in a pre-hospital setting. [3] Although fluid resuscitation is often the main treatment for UHS, the benefits are doubtful, as demonstrated in both animal and human studies. [4, 5] The rationale for upholding blood pressure in trauma patients is to maintain tissue oxygenation; however, more bleeding may result due to impairing the coagulation process. [6] Excessive fluid administration may cause brain edema, abdominal compartment syndrome, and acute respiratory distress syndrome. [7] Studies have shown that hypertonic saline (HTS) is useful for treating UHS patients. [8, 9] Moreover, HTS is thought to decrease lung tissue damage and pulmonary inflammation, and increase cellular protection in animal models of UHS. [10, 11] Studies of rats, dogs, swine, and pigs showed the relative efficacy of HTS fluid compared to normal saline (NS) for treating UHS. [12] [13] [14] [15] [16] [17] Studies in the literature have proven the benefits of HTS in cases of brain and cord trauma. [18] [19] [20] Modeling UHS in animals can lead us to a definite decision on the optimal fluid therapy for UHS in humans. Therefore, studies demonstrating the benefits of using hypertonic fluid in cases of human UHS [21, 22] led us to design a goat study to compare hypertonic and isotonic fluid, as well as no fluid treatment, in a clinically relevant model.
MATERIALS AND METHODS a. Animal Care Committee Approval
The study was approved by the Animal Care Committee of Tabriz University of Medical Sciences and reviewed by a group other than the authors according to procedures approved by the Report Review Committee.
b. Study Design
The study was a randomized trial conducted in a goat model. The model was based on a pre-hospital setting in which there is no access to packed red blood cells or other resuscitation options except fluids.
After the insertion of a 20G venous cannula in the vein of the goat's right ear, blood was obtained for primary and homogeneity comparison. All goats were anesthetized completely before the intervention with 5 mg/kg intravenous ketamine and 0.2 mg/kg diazepam, which was repeatedly administered every 10 minutes, as necessary. Following anesthesia, tracheostomy was performed on the goats. [23] Ventilators designed for humans were used. Ventilator settings were as follows: respiratory rate, 8; FiO 2 , 50%; positive end-expiratory pressure, 3; and tidal volume, 15 cc/kg. The goats were monitored intensively using heart rate and invasive continuous blood pressure monitoring. [24] c. Materials
The administered fluids included 20 cc/kg of normal saline (NS) [25] for the NS group, and 8 cc/kg of 3% saline for the HTS group.
d. Uncontrolled Hemorrhagic Shock Model
Thirty healthy male Mako goats with a mean weight of 28 kg (range: 15-40 kg) were included in the study. To decrease the incidence of regurgitation, goats underwent 12-hour preoperative fasting (except for water) before surgery. [24] After weighing the goats and obtaining the blood samples, ketamine and diazepam were administered. The goats underwent tracheostomy, and ventilation was performed using portable ventilators. Goats were randomly chosen to receive a specific resuscitation fluid. The 30 goats were assigned into three groups (10 in each group). The first group had no fluid resuscitation (NFR); the second group received NS; and the third group received HTS resuscitation.
After the insertion of an arterial line in the left carotid artery, mean arterial pressure was monitored continuously. Heart rate was monitored by ECG monitoring and recorded every five minutes. The right leg was ablated beneath the knee, so it caused bleeding from arteries, veins, muscles, and skin. No attempt was undertaken to mitigate the bleeding in order to simulate a real pre-hospital setting. Blood was collected and measured in a graded suction bottle.
Blood samples were obtained from the arterial line every 15 minutes to measure hemoglobin and pH. Goats have a blood volume of approximately 70 to 72 ml/kg blood. [26] To simulate the UHS setting, researchers waited for a blood loss equal to one-third of the goat's expected blood volume in all three groups (24 ml/kg). [27] Then, 20 ml/kg NS, 8 ml/kg HTS fluid (3%), or no fluids (for the NFR group) were administered rapidly. The starting point for the study was after saline infusion completion and was similar in all groups. The total infusion time was about 10 minutes in the NS group and less than 5 minutes in the HTS group. When their heart rates fell below 40 beats/min, the goats were announced dead and data collection was stopped. If a goat stayed alive for more than two hours, the resuscitation was deemed successful, and data collection for that goat was terminated. Throughout the whole procedure, bleeding was not controlled by the researcher in order to simulate UHS.
e. Statistical Analysis
All gathered information (i.e., the duration of the goat's life, tissue pH range, mean arterial pressure, and heart rate) was analyzed using the Statistical Package for the Social Sciences (SPSS, Windows version 15.0, SPSS, Inc., Chicago, IL). Of the non-parametric statistical tests, repeated measure analysis was used to evaluate the comparability of HTS, NS, and NFR groups and to compare the duration of life, amount of bleeding, blood pressure, and acidosis level. Survival analysis was performed by deriving Kaplan-Meier statistics and plots. The differences in survival of the three groups were investigated using log-rank (Mantel-Cox) testing, pooled over the strata. Analysis of variance was used to compare the groups. Significance was defined as p < 0.05.
RESULTS
The main features of UHS, including hemoglobin, heart rate, blood loss, mean arterial pressure, and pH were analyzed at 0, 15, 30, 45, 60, 75, 90, 105, and 120 minutes. Baseline characteristics and laboratory values were similar for all groups.
a. Bleeding Time
Because of massive bleeding, all the goats in the HTS group died in under one hour and the test was terminated for the HTS group. The bleeding time for the HTS group was 53±2.4 minutes. The bleeding stopped in the NS and NFR groups after 37±4.8 and 18.4±3.9 minutes, respectively, but the trial continued for both groups until the 120th minute. There was no significant difference between the NS and NFR groups (p>0.05). There was a significant difference between the NS and HTS groups, as well as between the NFR and HTS groups, at 60 minutes (p=0.015 and p<0.001, respectively).
b. Hemoglobin
There was no initial significant difference between the hemoglobin values of the groups. However, between 15 and 60 minutes, during which the HTS goats died, a significant difference appeared between the groups (p<0.001). The NFR group had much higher hemoglobin levels than the NS group, and the lowest hemoglobin values occurred in the HTS group. From the 60th minute to the 120th minute, the NFR group continued to have higher hemoglobin values than the NS group (p<0.001). Although decreasing hemoglobin levels were observed in all three groups, a rapid and severe decline occurred in the HTS group. Hemoglobin values for the NFR and NS groups remained parallel during the 120 minutes, but NFR group levels were statistically higher during the trial, except for during the first 15 minutes (Figure 1 ).
c. Heart Rate
Heart rate in the NFR and HTS groups increased at first, but heart rates were lower in the NFR group. Heart rate trends were irregular during the 120 minutes. In the HTS group, from the beginning until the 45th minute, heart rate increased rapidly and then fell rapidly toward zero until the 60th minute. At the 60th minute, heart rate fell below 40 beats/min, and the goats were excluded from the rest of the study. In the NS group, heart rate decreased during the first 35 minutes. In general, heart rates in both the NS and NFR groups increased gradually. Heart rate differences were not statistically significant between the three groups, and no welldefined pattern was observed (Figure 2 ).
d. Blood Loss
The blood loss gathered in the suction bottle was measured from minutes 15 to 120. Blood loss in the HTS group reached a mean of 1600 ml at the 30th minute. The HTS group had more than twice the blood loss of the other two groups, and blood loss in the NS group was higher than in the NFR group (minutes 15 to 30, p=0.021; minute 30 to end, p<0.001). The mean blood loss in the NS group was 1220 ml at the 35th minute. The mean blood loss in the NFR group was 610 ml at the 25th minute and did not increase considerably. Blood loss data are presented in Figure 3 . 
. Mean Arterial Pressure
In all groups, mean arterial pressure decreased in the first approximately 10 minutes. However, after receiving fluid therapy, mean arterial pressure in the NS group continued to fall until the 35th minute, after which, values in the NS group were continuously around 60 mmHg. Similarly, the NFR group experienced a drop in BP until the 28th minute. Mean arterial pressure in the HTS group decreased sharply toward zero in the first 60 minutes, and HTS goats were excluded since all died. All of these results were statistically significant (p<0.05), and mean arterial pressure values are presented in Figure 4 .
f. pH
No statistical difference between the pH values of the groups was observed in the beginning (p=0.21). Statistically significant differences occurred at the 15th minute (p=0.020) and were present during the rest of the study period (p<0.001).
The NFR group had the least acidity compared to the other two groups. The pH values in the HTS group were lower than in the NS group until the 60th minute. Data for pH are presented in Figure 5 .
In this trial, all the goats in the HTS group died before the 60th minute. In the NS and NFR groups, four goats and one goat died, respectively, during the 120 minutes of evaluation.
g. Survival Analysis Figure 6 shows the cumulative survival time for each treatment group. Kaplan-Meier analysis of survival until the 120th minute revealed an overall mean survival time of 87.4 minutes (S.E = 6.9). Mean survival times for the three groups were as follows: 119.0 (S.E = 0.95) for the NFR group, 105.2 (S.E = 5.83) for the NS group, and 38.0 (S.E = 4.38) for the HTS treatment group. Overall, 50% of all the goats survived. None of the goats that received HTS treatment survived; 60% of the NS group goats survived; and 90% of the untreated group survived the full 120 minutes. Log-rank (Mantel-Cox) statistics were significant when comparing the three groups pooled over the strata (chi-square = 41.72, p<0.001).
DISCUSSION
Previous protocols and advanced trauma life support teachings [28] have recommended that the primary treatment of UHS include controlling the source of external bleeding, and intravenous administration of crystalloids followed by packed blood cells through a catheter. [29] This approach has been challenged, and researchers have focused on different doses and types of fluids for treating UHS patients.
Goats are an appropriate mammal for modeling biomedical studies. Goats have relatively low fat proportions, so goats have similar weights to humans with low body mass. Their Figure 6 . Kaplan-Meier analysis revealing cumulative survival plotted against time and differentiated by study groups. * indicates a significant difference (p<0.05) between the NFR and NS groups. + indicates a significant difference (p<0.05) between the NS and HTS groups. # indicates a significant different (p<0.05) between the NFR and HTS groups. anatomy is the most similar to humans after monkeys and dogs. Therefore, tracheostomy and other procedures are easier to perform. Surgeries and ablations on dogs are difficult, and few monkeys are available. Goats are mammals and respond to shock more similarly to humans compared to rats. As a result, we chose to use a goat model. As far as we know, no previous studies have been performed of fluid therapy for UHS cases using a goat model.
Few studies have shown that resuscitation without fluid provides superior results in the treatment of UHS. In their rat study, Krausz et al. [30] showed that infusion of HTS and NS leads to more bleeding and hemodynamic instability. Studies of humans have shown that patients should not receive fluids at the accident scene in a UHS setting, and excessive fluid therapy leads to coagulopathy, increased acidosis, hypothermia, abdominal compartment syndrome, elevated intracranial pressure, and immunologic disorders. [17, [31] [32] [33] Fluid therapy increases the mortality rate in such conditions. [34] In our study, blood loss in the NFR group was lower than in the NS and HTS groups. Furthermore, the administration of fluid raised blood pressure levels, which interfered with the coagulation process. Contrastingly, not manipulating blood pressure and venous pressure caused less blood to leave the body; so pH levels in the NFR group decreased subsequently to values lower than in the NS and HTS groups. Theoretically, fluids increase blood volume. However, since more blood left the body, the increase in volume was offset by a decrease in hemoglobin in goats which received NS compared to the NFR goats. Hemoglobin levels decreased because of the addition of crystalloid. Heart rates in the NFR group increased slower than in the NS group during UHS. Thus, in cases of uncontrollable hemorrhage, such as abdominal or chest cavity bleeding or pelvic fracture, for which packed red blood cells are not available, the infusion of NS may not be beneficial.
Studies have demonstrated the benefits of administering hypertonic fluid to trauma patients. [7] [8] [9] 35] For example, HTS has been found to facilitate cerebral perfusion, decrease intracranial pressure, [36] restore blood pressure, and improve cardiac performance. [37] In their study of mice, Bahrami et al. [38] concluded that resuscitation with hypertonic fluid decreases the inflammatory process, but neither lung tissue damage nor mortality follow the same pattern following severe UHS. Krausz et al. [39] concluded that, compared to lactated ringer's solution, HTS was associated with less blood loss and improved survival in most groups of rats. Yu et al. [40] reported that limited fluid resuscitation improved the thermodynamics of pregnant rabbits, decreased inflammatory markers, and improved survival rate. In our study, using a model of UHS based on land-mine explosion and no access to packed blood cells, the infusion of HTS was the worst treatment option. HTS decreased hemoglobin levels and mean arterial pressure, and increased blood loss, heart rate, and pH severely and rapidly. No goat in the HTS group was still living after the 60th minute. Using HTS may be a valuable option for resuscitation in cases of controlled hemorrhagic shock, but our study demonstrated a model of UHS in which fluid therapy was not useful.
Ciesla et al. [41] showed that HTS attenuates the neutrophil cytotoxic response which leads to other complications. Additionally, Watters et al. [42] suggested that any fluid therapy dose may cause dysfunctional inflammatory response, which may explain the higher blood loss in the HTS group in our study. The development of a hypercoagulable state following an injury may also explain the blood loss. [17] Fluid therapy, especially HTS, attenuates this hypercoagulability, leading to more bleeding and other complications. In addition, HTS raises blood pressure and increases blood flow. These findings are in accordance with our study, in which more bleeding and higher blood pressure were observed in the HTS group. Additionally, HTS resuscitation causes more liquid to exit the intercellular space and enhances tissue acidosis. Similarly, in our study, the arterial blood gas results for the HTS group were comparable to those of the NFR and NS groups.
Our study has several limitations. We could not control for the effects of anesthesia, which would not be present in human cases of UHS. We did not use different doses of HTS or evaluate dextran. Due to the expense of goats and our limited funding, it was not possible to obtain a large number of animals for more exhaustive testing. Our study showed the role of fluids only in cases of early intervention. An extended evaluation is definitely needed to properly observe late outcomes and survival results. We limited the trial to 120 minutes, but all the goats in the HTS group died by the 60th minute. Therefore, we could not completely compare the three groups for the full two hours. However, no preliminary study using a smaller number of experimental subjects was performed.
Further studies and larger randomized clinical trials are required to confirm that, in cases of UHS, the administration of fluids is detrimental. More studies are also needed to determine the physiologic reasons that HTS and NS are worse than no fluid therapy in a UHS setting. Additional studies should focus on resuscitation methods and determining the situations in which fluid administration may augment tissue oxygenation and counterbalance potential harmful effects.
Conclusion
Our study shows that HTS may not be a suitable treatment for UHS when compared to NFR and NS groups, especially in settings where bleeding is uncontrollable. The NFR group had considerably better results compared to the HTS and NS groups for all features of UHS, such as hemoglobin levels, pH, bleeding time, and mean arterial pressure. NS and HTS fluids may worsen the condition in the pre-hospital field until surgical repair can be accomplished in the hospital.
